In recent years, Rybelsus has emerged as a game-changer for the treatment of Type 2 diabetes. The approval of this medication marks a significant advancement, as it represents the first oral GLP-1 receptor agonist on the market. Patients struggling to manage their blood sugar levels now have a powerful tool…